Skip to main content
SpringerLink
Log in

Laboratory Features of Cutaneous Lupus Erythematosus

  • Chapter
Cutaneous Lupus Erythematosus

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Black AJ, McLeod HL, Capell HA, Powrie RH, Matowe LK, Pritchard SC, Collie-Duguid ES, Reid DM (1998) Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med 129:716–718

    PubMed  Google Scholar 

  • Blum C, Zillikens D, Tony HP, Hartmann AA, Burg A (1993) Soluble interleukin-2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus. Hautarzt 44:290–295

    PubMed  Google Scholar 

  • Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE (1993) Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 119:1198–1208

    PubMed  Google Scholar 

  • Callen JP (1982) Chronic cutaneous lupus erythematosus: clinical, laboratory, therapeutic, and prognostic examination of 62 patients. Arch Dermatol 118:412–416

    Article  PubMed  Google Scholar 

  • Callen JP, Klein J (1988) Subacute cutaneous lupus erythematosus. Clinical, serologic, immunogenetic, and therapeutic considerations in 72 patients. Arthritis Rheum 31:1007–1013

    PubMed  Google Scholar 

  • Callen JP, Fowler JF, Kulick KB (1985) Serologic and clinical features of patients with discoid lupus erythematosus: relationship of antibodies to single-stranded deoxyribonucleic acid and of other antinuclear antibody subsets to clinical manifestations. J Am Acad Dermatol 13:748–755

    PubMed  Google Scholar 

  • Callen JP, Kulick KB, Stelzer G, Fowler JF (1986) Subacute cutaneous lupus erythematosus. Clinical, serologic, and immunogenetic studies of 49 patients seen in a non-referral setting. J Am Acad Dermatol 15:1227–1237

    PubMed  Google Scholar 

  • Chelbus E, Wolska H, Blaszyk M, Jablonska S (1998) Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications. J Am Acad Dermatol 38:405–412

    PubMed  Google Scholar 

  • Choudhry V, Madan N, Sood SK, Ghai OP (1978) Chloroquine-induced haemolysis and acute renal failure in subjects with G-6-PD deficiency. Trop Geogr Med 30:331–335

    PubMed  Google Scholar 

  • Cohen MR, Crosby D (1994) Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus. J Rheumatol 21:1665–1669

    PubMed  Google Scholar 

  • Committee on Safety of Medicines/Medicines Control Agency (1997) Blood dyscrasias and other ADRs with low-dose methotrexate. Current Problems 23:12–18

    Google Scholar 

  • Custer RP (1946) Aplastic anemia in soldiers treated with Atabrine (quinacrine). Am J Med Sci 212:211–224

    Google Scholar 

  • Dahl MGC (1984) Folate depletion in psoriatics on methotrexate. Br J Dermatol 111(Suppl 26):18

    PubMed  Google Scholar 

  • Dodd HJ, Kirby JD, Munro DD (1985) Megaloblastic anaemia in psoriatic patients treated with methotrexate. Br J Dermatol 112:630–631

    PubMed  Google Scholar 

  • Ettinger WH, Hazzard WR (1988) Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men. Metabolism 37:1055–1058

    Article  PubMed  Google Scholar 

  • Fonseca E, Alvarez R, Gonzalez MR, Pascual D (1992) Prevalence of anticardiolipin antibodies in subacute cutaneous lupus erythematosus. Lupus 1:265–268

    PubMed  Google Scholar 

  • Franceschini F, Calzavara-Pinton P, Quinzanini M, Cavazzana I, Bettoni L, Zane C, Facchetti F, Airo P, McCauliffe DP, Cattaneo R (1998) Chilbains lupus erythematosus is associated with antibodies to SSA/Ro. Lupus 8:215–219

    Article  Google Scholar 

  • Gaffney K, Scott DG (1998) Azathioprine and cyclophasphamide in the treatment of rheumatoid arthritis. Br J Rheum 37:824–836

    Article  Google Scholar 

  • Johansson-Stephansson E, Koskimes S, Partanen J, Kariniemi AL (1989) Subacute cutaneous lupus erythematosus: genetic markers and clinical and immunological findings in patients. Arch Dermatol 125:791–796

    Article  PubMed  Google Scholar 

  • Kersley GD, Palin AG (1959) Amodiaquine and hydroxychloroquine in rheumatoid arthritis. Lancet ii:886–888

    Article  Google Scholar 

  • Konstadoulakis MM, Kroubouzos G, Tosca A, Piperingos G, Marafelia P, Konstadoulakis M, Varelzidis A, Koutras DA (1993) Thyroid autoantibodies in the subsets of lupus erythematosus: correlation with other autoantibodies and thyroid function. Thyroidol Clin Exp 5:1–7

    PubMed  Google Scholar 

  • Kremer JM, Alarcon GS, Lightfoot RW Jr, Willkens RF, Furst DE, Williams HJ, Dent PB, Weinblatt ME (1994) Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum 37:1829–1830

    PubMed  Google Scholar 

  • Landewe RB, Vergouwen MS, Goeei The SG, Van Rijthoven AW, Breedveld FC, Dijkmans BA (1995) Antimalarial drug induced decrease in creatinine clearance. J Rheumatol 22:34–37

    PubMed  Google Scholar 

  • Lee LA, Roberts CM, Frank MB, McCubbin VR, Reichlin M (1994) The autoantibody response to Ro/SSA in cutaneous lupus erythematosus. Arch Dermatol 130:1262–1268

    Article  PubMed  Google Scholar 

  • Ludolph A, Matz DR (1982) Electrophysiologic changes in thalidomide neuropathy under treatment for discoid LE. EEG EMG 13:167–170

    PubMed  Google Scholar 

  • Mayou SC, Wojnorowska F, Lovell CR, Asherson RA, Leigh IM (1988) Anticardiolipin and antinuclear antibodies in discoid lupus erythematosus — their clinical significance. Clin Exp Dermatol 13:389–392

    PubMed  Google Scholar 

  • Meyerson MA, Cohen PR (1994) Dapsone-induced aplastic anemia in a woman with bullous systemic lupus erythematosus. Mayo Clin Proc 69:1159–1162

    PubMed  Google Scholar 

  • Millard LG, Rowell NR (1979) Abnormal laboratory test results and their relationship to prognosis in discoid lupus erythematosus. A long-term follow-up study of 92 patients. Arch Dermatol 115:1055–1058

    Article  PubMed  Google Scholar 

  • Mok CC, Lau CS, Woon Sing Wong R (1998) Toxicities of dapsone in the treatment of cutaneous manifestations of rheumatic diseases. J Rheumatol 25:1246–1247

    PubMed  Google Scholar 

  • Musabayane CT, Ndhlovu CE, Balment RJ (1994) The effects of oral chloroquine administration on kidney function. Renal Fail 16:221–228

    Google Scholar 

  • Neuberger J (1995) Methotrexate and liver disorders. Prescribers’ J 35:158–63

    Google Scholar 

  • O’Loughlin S, Schroeter AL, Jordan RE (1978) A study of lupus erythematosus with particular reference to generalized discoid lupus. Br J Dermatol 99:1–11

    PubMed  Google Scholar 

  • Orth DN, Kovacs WJ (1998) The adrenal cortex. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds) Williams textbook of endocrinology, 9th ed. WB Saunders, Philadelphia, pp 517–664

    Google Scholar 

  • Petri M, Lakatta C, Magder L, Goldman D (1994) Effects of prednisone and hydroxychloroquine on coronary artery disease rise factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 96:254–259

    Article  PubMed  Google Scholar 

  • Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR (1991) Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 21:55–64

    Article  PubMed  Google Scholar 

  • Polano MK, Cats A, van Olden GAJ (1965) Agranulocytosis following treatment with hydroxychloroqine sulfate. Lancet 1:1275

    Article  Google Scholar 

  • Provost TT, Ratrie H (1990) Autoantibodies and autoantigens in lupus erythematosus and Sjogren’s syndrome. Curr Probl Dermatol 2:150–208

    Google Scholar 

  • Prystowsky SD, Kerndon JH, Gilliam JN (1975) Chronic cutaneous lupus erythematosus (DLE): a clinical and laboratory investigation of 80 patients. Medicine 55:183–191

    Google Scholar 

  • Rowell NR (1984) The natural history of lupus erythematosus. Clin Exp Dermatol 9:217–231

    PubMed  Google Scholar 

  • Sanchez NP, Peters MS, Winkelmann RK (1981) The histopathology of lupus erythematosus panniculitis. J Am Acad Dermatol 5:673–680

    PubMed  Google Scholar 

  • Schimmer BP, Parker KL (1996) Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JE, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (eds) The pharmacological basis of therapeutics, 9th ed. McGraw-Hill, New York, pp 1459–1485

    Google Scholar 

  • Shi SY, Feng SF, Liao KH, Fang L, Kang KF (1987) Clinical study of 30 cases of subacute cutaneous lupus erythematosus. Chin Med J 100:45–48

    PubMed  Google Scholar 

  • Sontheimer RD (1989) Subacute cutaneous lupus erythematosus: a decade’s perspective. Med Clin North Am 73:1073–1090

    PubMed  Google Scholar 

  • Sontheimer RD, Provost TT (1997) Cutaneous manifestations of lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois’ lupus erythematosus, 5th ed. Williams & Wilkins, Philadelphia, pp 569–623

    Google Scholar 

  • Sontheimer RD, Maddison PJ, Richlin M, Jordon RE, Stasny P, Gilliam JN (1982) Serologic and HLA associations in subacute cutaneous lupus erythematosus: a clinical subset of lupus erythematosus. Ann Intern Med 97:664–671

    PubMed  Google Scholar 

  • Sturdevant RA, Singleton JW, Derern JL, Law DH, McCleery JL (1979) Azathioprine-related pancreatitis in patients with Crohn’s disease. Gastroenterology 77:883–886

    PubMed  Google Scholar 

  • Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) Special article: the 1982 revised criteria for the classification of systemic lupus erythmatosus. Arthritis Rheum 25:1271–1277

    PubMed  Google Scholar 

  • Tebbe B, Mansmann U, Wollina U, Auer-Grumbach P, Licht-Mbalyohere A, Arensmeier M, Orfanos CE (1997) Markers in cutaneous lupus erythematosus indicating systemic involvement — a multicenter study on 296 patients. Acta Derm Venereol 77:305–308

    PubMed  Google Scholar 

  • Wallace DJ (1989) The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination. Semin Arthritis Rheum 18:282–296

    Article  PubMed  Google Scholar 

  • Wallace DJ, Metzger AL, Stecher VJ, Turnbull BA, Kern PA (1990) Cholesterol-lowering effects of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids. Am J Med 89:322–326

    Article  PubMed  Google Scholar 

  • Wallace DJ, Pistiner M, Nessim S, Metzger AL, Klinenberg JR (1992) Cutaneous lupus erythematosus without systemic lupus erythematosus: clinical and laboratory features. Semin Arthritis Rheum 21:221–226

    Article  PubMed  Google Scholar 

  • Winkelmann RK, Peters MS (1982) Lupus panniculitis. Dermatol Update 135

    Google Scholar 

  • Wysenbeek AJ, Guedj D, Amit M, Weinberger A (1992) Rash in systemic lupus erythematosus: prevalence and relation to cutaneous and non-cutaneous disease manifestations. Ann Rheum Dis 51:717–719

    PubMed  Google Scholar 

Download references

Authors
  1. Shuntaro Shinada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel J. Wallace
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hautklinik, Universitätsklinikum Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany

    Annegret Kuhn  & Thomas Ruzicka  & 

  2. HELIOS Klinikum Wuppertal Klinik für Dermatologie, Allergologie und Umweltmedizin, Universitätsklinikum Witten-Herdecke, Arrenbergerstraße 20, 42117, Wuppertal, Germany

    Percy Lehmann

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Shinada, S., Wallace, D.J. (2005). Laboratory Features of Cutaneous Lupus Erythematosus. In: Kuhn, A., Lehmann, P., Ruzicka, T. (eds) Cutaneous Lupus Erythematosus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26581-3_23

Download citation

  • DOI: https://doi.org/10.1007/3-540-26581-3_23

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-44266-0

  • Online ISBN: 978-3-540-26581-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation